- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03055819
Evaluation of Patient and Physician Satisfaction With the Zift eLevatIon of Facial Tissue Clinical Study (LIFT)
August 2, 2023 updated by: Zift, LLC
The LIFT study will document the first clinical use of the ZiftLift Tissue Anchor in a browlift for patients with age-related brow ptosis.
It is a single arm, open label multicenter study, to evaluate the safety and efficacy of the Zift Lift System.
Up to 20 subjects in up to 3 sites will be enrolled in this study.
Data from this trial will be used to confirm the device safety and efficacy and provide inputs to further refine the device design and procedure technique for future device iterations
Study Overview
Detailed Description
The LIFT study will document the first clinical use of the ZiftLift Tissue Anchor in a browlift for patients with age-related brow ptosis.
It is a single arm, open label multicenter study, to evaluate the safety and efficacy of the Zift Lift System.
Up to 20 subjects in up to 3 sites will be enrolled in this study.
Data from this trial will be used to confirm the device safety and efficacy and provide inputs to further refine the device design and procedure technique for future device iterations Subjects with signed informed consents and who meet all the inclusion and none of the exclusion criteria and are treated with the device will be considered enrolled in the study.
An interim report will be created after the first 20 patients has completed their 90 follow up and the data monitored.
The 20 patients, 90 day report may be submitted to FDA and other agencies for product clearance and registrations.
After FDA clearance has been obtained, the study may be converted to a post-market study for the long term follow up.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Edina, Minnesota, United States, 55435
- Centennial Lakes Surgery Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 73 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Able to provide informed consent to the treatment
- Willing and able to participate in all the required follow-ups
- Over 18 years of age
- Under 75 years of age
- Brow ptosis and/or functional limitations such as vision defects due to tissue laxity caused by aging
Exclusion Criteria:
- Known allergies to local anesthesia
- Currently undergoing chemotherapy or radiation therapy for cancer
- Known advanced osteoporosis that may lead to skull thinning
- Taking long-term immunosuppressant therapy
- Taking chronic anticoagulation therapy (including ASA and NSAIDS) which can't be stopped for 10 days before treatment.
- Unable or unwilling to participate in follow-up examinations
- Evidence of brow soft tissue thickness less than 4mm by physical exam, ultrasound or direct probe (probe at the time of procedure)
- Stroke or TIE (Transient Ischemic Event) within the past 6 months and currently on anti-platelet or other blood thinners
- Chronic facial paralysis due to trauma, Bells Palsy, or similar etiology
- Treatment with neurotoxin in the past 6 months and during the study period. Subjects may undergo a neurotoxin washout for 6 months prior to study participation
- Planned surgical procedures, fillers or other facial procedures during the study period.
- Planned modification of the eyebrows (to include plucking or shaving) during the study period
- Planned MRI during the study period
- Known nickel allergy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ZiftLift Tissue Anchor
Use of ZiftLift Tissue Anchors for Brow Lift
|
Minimally Invasive Brow Lift
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Brow Elevation
Time Frame: 90 days, 6 months, 1, 2, 3 and 4 years
|
Change in brow elevation in mm from baseline to 90 days, with long term follow-up out to 4 years
|
90 days, 6 months, 1, 2, 3 and 4 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Satisfaction
Time Frame: 90 days, 6 months, 1, 2, 3 and 4 years
|
Patient Satisfaction using the Face-Q survey
|
90 days, 6 months, 1, 2, 3 and 4 years
|
Physician Satisfaction
Time Frame: 90 days, 6 months, 1, 2, 3 and 4 years
|
Physician Satisfaction with Cosmetic Result.
7 metrics on all patients at all time points using a survey tool.
|
90 days, 6 months, 1, 2, 3 and 4 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Peter A Hilger, MD, Centennial Lakes Surgery Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 3, 2017
Primary Completion (Actual)
April 2, 2018
Study Completion (Actual)
October 31, 2018
Study Registration Dates
First Submitted
February 14, 2017
First Submitted That Met QC Criteria
February 14, 2017
First Posted (Actual)
February 16, 2017
Study Record Updates
Last Update Posted (Actual)
August 7, 2023
Last Update Submitted That Met QC Criteria
August 2, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1068-001Rev3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Senile Ptosis
-
Kenneth BeerMedicis Pharmaceutical CorporationCompleted
-
Meir Medical CenterUnknown
-
Maastricht University Medical CenterWithdrawn
-
Ain Shams UniversityCompletedMild Ptosis | Moderate PtosisEgypt
-
Sheba Medical CenterUnknownSurgical Procedure, Unspecified | Ptosis, Eyelid | Ptosis; Eyelid, CongenitalIsrael
-
1st SurgiConceptEVAMEDRecruiting
-
The New York Eye & Ear InfirmaryCompleted
-
Sohag UniversityNot yet recruitingCongenital PtosisEgypt
-
Shanghai Jiao Tong University School of MedicineUnknown
-
Eyelid and Facial ConsultantsOchsner Health SystemUnknownBrow Ptosis | Facial ScarringUnited States
Clinical Trials on Brow Lift
-
Assiut UniversityUnknown
-
University of FloridaCompletedPharmacokineticsUnited States
-
Zhen Jun WangPeking University Third Hospital; Shaanxi Provincial People's Hospital; Tianjin... and other collaboratorsUnknownAnorectal Fistula | Extracellular Matrix AlterationChina
-
Mansoura UniversityActive, not recruitingPartial Edentulism Class 2 Due to Periodontal DiseaseEgypt
-
University of FloridaActive, not recruitingBiomechanics | Limb Length DiscrepancyUnited States
-
Assiut UniversityUnknown
-
Duke UniversityNational Center for Complementary and Integrative Health (NCCIH)CompletedCOVID-19 | Cardiorespiratory FailureUnited States
-
Sykehuset Innlandet HFWithdrawn
-
VNU University of Medicine and PharmacyCompletedBone ResorptionVietnam
-
University of California, Los AngelesCompletedSubstance Abuse | Adolescent BehaviorsUnited States